Pasquale Rescigno

13PUBLICATIONS
106CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 09, 2026
Exploring DNA Damage Repair Therapeutics in Prostate Cancer beyond BRCAness.

Fabrizio Di Costanzo, Jack Williamson, Craig N Robson

|Jul 08, 2025
Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 Study.

Mimma Rizzo, Andrey Soares, Shilpa Gupta

|Aug 19, 2024
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab.

Alessandra Damassi, Malvina Cremante, Alessio Signori

|Jun 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).

Fabio Catalano, Matteo Brunelli, Alessio Signori

|May 17, 2024
Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of "palateau".

Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori

|Apr 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).

Fabio Catalano, Matteo Brunelli, Alessio Signori

Pageof 3

Frequent Collaborators

9 joint publications

Sebastiano Buti

9 joint publications

Giuseppe Luigi Banna

9 joint publications

Giuseppe Fornarini

9 joint publications

Sara Elena Rebuzzi